Transforming viral defense: The role of Monoclonal antibodies in modern medicine
Dr. Rachael Wolters, DVM, PhD, is an expert in the field of antiviral monoclonal antibodies. She earned her Doctor of Veterinary Medicine (DVM) from the University of Tennessee and her PhD from Vanderbilt University, where she conducted her research in the laboratory of Dr. James Crowe. During her time at Vanderbilt, Dr. Wolters focused on the discovery and characterization of broadly neutralizing human monoclonal antibodies against influenza type B virus. Currently, Dr. Wolters holds a Research Assistant Professor position at the Oregon National Primate Research Center (ONPRC) in the Department of Pathobiology and Immunology, collaborating with Dr. Ann Hessell. Her work at ONPRC centers on developing and enhancing antiviral human monoclonal antibodies, with a particular focus on their application in HIV-1 immunology and other viral pathogens. Her contributions have been recognized through various awards and grants, including an early investigator NIH K01 grant.

In her talk, Dr. Wolters will delve into the past, present, and future of antiviral monoclonal antibodies, providing insights from her extensive research experience and outlining potential future directions in this rapidly evolving field.

This seminar will be in person only
Date: 20 September 2024, 12:00 (Friday, 22nd week, Trinity 2024)
Venue: Wellcome Trust Centre for Human Genetics, Headington OX3 7BN
Venue Details: Room A
Speaker: Dr Rachael Wolters (Oregon Health & Science University)
Organising department: Wellcome Trust Centre for Human Genetics
Organiser: Victoria Fallon (University of Oxford)
Organiser contact email address: victoria.fallon@well.ox.ac.uk
Host: Professor Miles Carroll (University of Oxford)
Booking required?: Not required
Audience: Members of the University only
Editors: Victoria Fallon, Alba Fernandez Santana